Atorvastatin load for Reduction of MYocardial Damage during Angioplasty of ST-segment Elevation Myocardial Infarction patients.
Phase of Trial: Phase IV
Latest Information Update: 21 May 2012
At a glance
- Drugs Atorvastatin (Primary)
- Indications Cardiovascular disorders; Myocardial infarction; Myocardial reperfusion injury
- Focus Therapeutic Use
- Acronyms ARMYDA-STEMI
- 21 May 2012 Planned end date changed from 1 Dec 2012 to 31 Dec 2013 as reported by Chinese Clinical Trial Register.
- 25 Mar 2011 New trial record